Name
Isotopia Molecular Imaging
What We Do
✨Isotopia: Advancing Radiopharmaceutical Solutions with Reliable Lu-177 and Tb-161 Supply ✨

Isotopia USA, headquartered in Indianapolis, Indiana, is dedicated to ensuring a seamless and dependable supply of Lutetium-177 (Lu-177) for radiopharmaceutical therapies.

With a strong focus on overcoming logistical challenges, we streamline isotope delivery by eliminating customs delays, mitigating flight cancellations, and providing real-time tracking—ensuring on-time delivery every time.

Our state-of-the-art, GMP-compliant facility spans approximately 40,000 square feet and features aseptic manufacturing and sterility testing cleanrooms, advanced Quality Control (QC) and microbiology laboratories, and dedicated engineering spaces.

By Q3 2025, Isotopia USA will commence commercial-scale production of GMP-grade Lu-177 n.c.a., supporting customers through process validation and clinical trials.

Beyond Lu-177, we are expanding our capabilities to include Terbium-161 and other breakthrough isotopes, as well as the production of finished drug products for preclinical, clinical, and commercial applications.

As a global leader in nuclear medicine, Isotopia is committed to innovation, patient safety, and reliability. Our long-term partnerships with nuclear reactors and a secure supply chain ensure continuous delivery to patients worldwide.
Founded
2007
Categories
PET, PET/CT, Pharmaceuticals, Radioisotopes, Radiopharmaceuticals, Services, SPECT, SPECT/CT
Address
17075 Oak Ridge Rd, Westfield
Indianapolis, IN 46074
United States
Facebook
LinkedIn
Twitter (X)

Listings

Relevance
Lu-177 Targeted Molecular Radiotherapy

Videos

Relevance